ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.110,38
-0,16%
S&P 500
5.667,20
0,64%
US Dollar vs BRL
5,4259
-0,41%
Bitcoin
65.126,04
0,42%
Brent Oil
83,315
-1,22%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Nightstar Therapeutics Plc ADS (NITE)

  7. Nightstar Therapeutics Plc ADS (NITE) Notícias

NITE

Nightstar Therapeutics Plc ADS (NITE)

Nightstar Therapeutics Plc ADS
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NITE
DataHoraFonteTítuloCódigoCompanhia
12/04/201004:00PR Newswire (US)Knight Appoints Didier Bankole Vice President of Sales for the Electronic Trading Group in EuropeNASDAQ:NITENightstar Therapeutics Plc ADS
07/04/201016:53Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:NITENightstar Therapeutics Plc ADS
31/03/201018:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:NITENightstar Therapeutics Plc ADS
30/03/201008:30PR Newswire (US)Knight Capital Group to Acquire Urban Financial GroupNASDAQ:NITENightstar Therapeutics Plc ADS
17/03/201005:00PR Newswire (US)Knight Libertas to Host Credit Opportunities Conference on March 25 in LondonNASDAQ:NITENightstar Therapeutics Plc ADS
16/03/201008:15PR Newswire (US)Knight Capital Group Announces Pricing of $325 Million of Cash Convertible Senior Subordinated NotesNASDAQ:NITENightstar Therapeutics Plc ADS
15/03/201018:33Dow Jones NewsBATS Warns Against Blanket Regulation For Off-Exchange TradeNASDAQ:NITENightstar Therapeutics Plc ADS
15/03/201004:01PR Newswire (US)Knight Capital Group Announces Proposed Offering of $300 Million of Cash Convertible Senior Subordinated NotesNASDAQ:NITENightstar Therapeutics Plc ADS
12/03/201019:29Dow Jones News2nd UPDATE: Direct Edge Wins Exchange Status From SECNASDAQ:NITENightstar Therapeutics Plc ADS
12/03/201019:08Dow Jones NewsUPDATE: Direct Edge Wins Exchange Status From SECNASDAQ:NITENightstar Therapeutics Plc ADS
12/03/201009:30PR Newswire (US)Knight Capital Group Releases February 2010 Volume StatisticsNASDAQ:NITENightstar Therapeutics Plc ADS
05/03/201010:30PR Newswire (US)Knight Capital Group to Present at Raymond James 31st Annual Institutional Investors ConferenceNASDAQ:NITENightstar Therapeutics Plc ADS
04/03/201017:42Dow Jones NewsUPDATE: Finra Panel Reverses Ruling Against Knight ExecutivesNASDAQ:NITENightstar Therapeutics Plc ADS
04/03/201014:25Dow Jones NewsFinra Panel Reverses Ruling Against Knight Securities ExecutivesNASDAQ:NITENightstar Therapeutics Plc ADS
02/03/201018:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NITENightstar Therapeutics Plc ADS
24/02/201018:23Edgar (US Regulatory)Annual Report (10-K)NASDAQ:NITENightstar Therapeutics Plc ADS
23/02/201016:00PR Newswire (US)New Study Examines Recent Changes to U.S. Market Structure and the Impact on InvestorsNASDAQ:NITENightstar Therapeutics Plc ADS
23/02/201010:30PR Newswire (US)Knight Expands Institutional Options CapabilitiesNYSE:NITE
18/02/201019:15PR Newswire (US)Knight Capital Group, Inc. Reports Inducement Grants Under NASDAQ Marketplace Rule 5635NASDAQ:NITENightstar Therapeutics Plc ADS
12/02/201016:43Edgar (US Regulatory)Form 13F Holdings Report (13F-HR)NASDAQ:NITENightstar Therapeutics Plc ADS
12/02/201010:30PR Newswire (US)Knight Capital Group Releases January 2010 Volume StatisticsNASDAQ:NITENightstar Therapeutics Plc ADS
09/02/201018:59Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:NITENightstar Therapeutics Plc ADS
09/02/201011:30PR Newswire (US)Knight Introduces Algorithmic Pairs Trading CapabilitiesNYSE:NITENULL
29/01/201017:54Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:NITENightstar Therapeutics Plc ADS
21/01/201010:00PR Newswire (US)Knight Capital Group Releases December 2009 Volume StatisticsNASDAQ:NITENightstar Therapeutics Plc ADS
21/01/201009:00PR Newswire (US)Knight Capital Group Announces Consolidated Earnings of $0.44 Per Diluted Share and Earnings From Continuing Operations of $0.45NASDAQ:NITENightstar Therapeutics Plc ADS
14/01/201018:50Dow Jones NewsDespite LaBranche's Exit, NYSE Sees Life In Specialist ModelNASDAQ:NITENightstar Therapeutics Plc ADS
11/01/201011:30PR Newswire (US)Knight Libertas Appoints Sean Dowd as Managing Director, Co-Head of U.S. Credit SalesNYSE:NITE
05/01/201013:00PR Newswire (US)Sidoti & Company Reveals Three Keys to Micro Cap Investing for 2010NASDAQ:NITENightstar Therapeutics Plc ADS
05/01/201006:30PR Newswire (US)Knight Libertas UK Appoints Ron Thompson as Managing Director, Global Head of ABS StrategyNASDAQ:NITENightstar Therapeutics Plc ADS
 Apresentando as notícias mais relevantes sobre:NASDAQ:NITE

Seu Histórico Recente

BOV
TPIS3M
TRIUNFO PART ON
LSE
RS49
Bank Mont.27
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados